One-step conservative surgery vs hysterectomy for placenta accreta spectrum: a feasibility randomized controlled trial

Placenta accreta spectrum is a serious condition associated with significant maternal morbidity and even mortality. The recommended treatment is hysterectomy. An alternative is 1-step conservative surgery, which involves the en bloc resection of the myometrium affected by placenta accreta spectrum a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics & gynecology MFM 2024-06, Vol.6 (6), p.101333, Article 101333
Hauptverfasser: Nieto-Calvache, Álbaro José, Aryananda, Rozi Aditya, Palacios-Jaraquemada, José Miguel, Cininta, Nareswari, Grace, Ariani, Benavides-Calvache, Juan Pablo, Campos, Clara Ivette, Messa-Bryon, Adriana, Vallecilla, Liliana, Sarria, Daniela, Galindo, Juan Sebastian, Galindo-Velasco, Valentina, Rivera-Torres, Luisa Fernanda, Burgos-Luna, Juan Manuel, Bhide, Amarnath
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page 101333
container_title American journal of obstetrics & gynecology MFM
container_volume 6
creator Nieto-Calvache, Álbaro José
Aryananda, Rozi Aditya
Palacios-Jaraquemada, José Miguel
Cininta, Nareswari
Grace, Ariani
Benavides-Calvache, Juan Pablo
Campos, Clara Ivette
Messa-Bryon, Adriana
Vallecilla, Liliana
Sarria, Daniela
Galindo, Juan Sebastian
Galindo-Velasco, Valentina
Rivera-Torres, Luisa Fernanda
Burgos-Luna, Juan Manuel
Bhide, Amarnath
description Placenta accreta spectrum is a serious condition associated with significant maternal morbidity and even mortality. The recommended treatment is hysterectomy. An alternative is 1-step conservative surgery, which involves the en bloc resection of the myometrium affected by placenta accreta spectrum along with the placenta, followed by uterine reconstruction. Currently, there are no studies comparing the 2 techniques in the setting of a randomized controlled trial. We performed a prospectively registered multicenter randomized controlled trial comparing hysterectomy with 1-step conservative surgery. The aim was to collect feasibility and clinical outcomes of the 2 techniques in women assigned to hysterectomy or 1-step conservative surgery. In addition to assessing participants’ willingness to be randomized, we also collected data on intraoperative blood loss, transfusion requirement, serious adverse event, and other clinical outcomes. Sixty women with strong antenatal suspicion of placenta accreta spectrum were assigned randomly to either hysterectomy (n=31) or 1-step conservative surgery (n=29). During a 20-month period, 60 of the 64 eligible patients (93.7%) underwent randomization. Intention-to-treat analysis showed that the clinical outcomes for 1-step conservative surgery were comparable to those of hysterectomy (median intraoperative blood loss, 1740 mL [interquartile range, 1010–2410] vs 1500 mL [interquartile range, 1122–2753]; odds ratio, 1 [1–1]; P=.942; median duration of surgery, 135 minutes [interquartile range, 111–180] vs 155 minutes [interquartile range, 120–185]; odds ratio, 0.99 [0.98–1]; P=.151; transfusion rate, 58.6% vs 61.3%; odds ratio, 0.96 [0.83–1.76]; P=.768; and adverse event rate, 17.2% vs 9.7%; odds ratio, 1.77 [0.43–10.19]; P=.398; respectively). In the subgroup of women with type 1 class on topographic classification, all participants allocated to 1-step surgery had successful outcomes, which were superior to those of hysterectomy. This was evidenced by the shorter surgery duration (median, 125 [interquartile range, 98–128] vs 180 [129–226] minutes; P=.002), lower transfusion rates (46.2% vs 82.4%), and fewer units of red blood cells transfused (median, 1 [interquartile range, 1–1.8] vs 3 [interquartile range, 2–4] units; P=.007). A randomized controlled trial comparing 2 surgical techniques for the treatment of placenta accreta spectrum is feasible. One-step conservative repair is a valid alternative to hysterectomy in the lar
doi_str_mv 10.1016/j.ajogmf.2024.101333
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2954778251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2589933324000594</els_id><sourcerecordid>2954778251</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-677aef9409dbfd0ac373191d74b91ee9d7486e41f5f7bbaf372757675c09005f3</originalsourceid><addsrcrecordid>eNp9kMtu1TAQhi0EolXpGyDkJZuc-hrHLJBQVS5SpW5gbTnOuPgoiYOdRApPj6MUxKqr-TXzz-1D6C0lJ0pofXM-2XN8HPyJESb2FOf8BbpkstGVLvrlf_oCXed8JoQwKoRk9Wt0wRshG16zS7Q-jFDlGSbs4pghrXYOK-C8pEdIG14z_rmVcgI3x2HDPiY89dbBOFtsnUtQYp5KNS3DB2yxB5tDG_owbzjZsYtD-A3dPnxOse-LnFOw_Rv0yts-w_VTvEI_Pt99v_1a3T98-Xb76b5y5bq5qpWy4LUgumt9R6zjilNNOyVaTQF0EU0NgnrpVdtazxVTUtVKOqIJkZ5foffH3CnFXwvk2QwhO-h7O0JcsmFaCqUaJmmxisPqUsw5gTdTCoNNm6HE7NDN2RzQzQ7dHNBL27unDUs7QPev6S_iYvh4GKD8uQZIJrsAo4Mu7FRNF8PzG_4A6QyW_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2954778251</pqid></control><display><type>article</type><title>One-step conservative surgery vs hysterectomy for placenta accreta spectrum: a feasibility randomized controlled trial</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Nieto-Calvache, Álbaro José ; Aryananda, Rozi Aditya ; Palacios-Jaraquemada, José Miguel ; Cininta, Nareswari ; Grace, Ariani ; Benavides-Calvache, Juan Pablo ; Campos, Clara Ivette ; Messa-Bryon, Adriana ; Vallecilla, Liliana ; Sarria, Daniela ; Galindo, Juan Sebastian ; Galindo-Velasco, Valentina ; Rivera-Torres, Luisa Fernanda ; Burgos-Luna, Juan Manuel ; Bhide, Amarnath</creator><creatorcontrib>Nieto-Calvache, Álbaro José ; Aryananda, Rozi Aditya ; Palacios-Jaraquemada, José Miguel ; Cininta, Nareswari ; Grace, Ariani ; Benavides-Calvache, Juan Pablo ; Campos, Clara Ivette ; Messa-Bryon, Adriana ; Vallecilla, Liliana ; Sarria, Daniela ; Galindo, Juan Sebastian ; Galindo-Velasco, Valentina ; Rivera-Torres, Luisa Fernanda ; Burgos-Luna, Juan Manuel ; Bhide, Amarnath</creatorcontrib><description>Placenta accreta spectrum is a serious condition associated with significant maternal morbidity and even mortality. The recommended treatment is hysterectomy. An alternative is 1-step conservative surgery, which involves the en bloc resection of the myometrium affected by placenta accreta spectrum along with the placenta, followed by uterine reconstruction. Currently, there are no studies comparing the 2 techniques in the setting of a randomized controlled trial. We performed a prospectively registered multicenter randomized controlled trial comparing hysterectomy with 1-step conservative surgery. The aim was to collect feasibility and clinical outcomes of the 2 techniques in women assigned to hysterectomy or 1-step conservative surgery. In addition to assessing participants’ willingness to be randomized, we also collected data on intraoperative blood loss, transfusion requirement, serious adverse event, and other clinical outcomes. Sixty women with strong antenatal suspicion of placenta accreta spectrum were assigned randomly to either hysterectomy (n=31) or 1-step conservative surgery (n=29). During a 20-month period, 60 of the 64 eligible patients (93.7%) underwent randomization. Intention-to-treat analysis showed that the clinical outcomes for 1-step conservative surgery were comparable to those of hysterectomy (median intraoperative blood loss, 1740 mL [interquartile range, 1010–2410] vs 1500 mL [interquartile range, 1122–2753]; odds ratio, 1 [1–1]; P=.942; median duration of surgery, 135 minutes [interquartile range, 111–180] vs 155 minutes [interquartile range, 120–185]; odds ratio, 0.99 [0.98–1]; P=.151; transfusion rate, 58.6% vs 61.3%; odds ratio, 0.96 [0.83–1.76]; P=.768; and adverse event rate, 17.2% vs 9.7%; odds ratio, 1.77 [0.43–10.19]; P=.398; respectively). In the subgroup of women with type 1 class on topographic classification, all participants allocated to 1-step surgery had successful outcomes, which were superior to those of hysterectomy. This was evidenced by the shorter surgery duration (median, 125 [interquartile range, 98–128] vs 180 [129–226] minutes; P=.002), lower transfusion rates (46.2% vs 82.4%), and fewer units of red blood cells transfused (median, 1 [interquartile range, 1–1.8] vs 3 [interquartile range, 2–4] units; P=.007). A randomized controlled trial comparing 2 surgical techniques for the treatment of placenta accreta spectrum is feasible. One-step conservative repair is a valid alternative to hysterectomy in the large majority of cases, but this can only be ascertained following intraoperative surgical staging. El resumen está disponible en Español al final del artículo.</description><identifier>ISSN: 2589-9333</identifier><identifier>EISSN: 2589-9333</identifier><identifier>DOI: 10.1016/j.ajogmf.2024.101333</identifier><identifier>PMID: 38458362</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject><![CDATA[accreta ; Adult ; Blood Loss, Surgical - prevention & control ; Blood Loss, Surgical - statistics & numerical data ; Blood Transfusion - methods ; Blood Transfusion - statistics & numerical data ; Cesarean Section - adverse effects ; Cesarean Section - methods ; Cesarean Section - statistics & numerical data ; Conservative Treatment - methods ; Conservative Treatment - statistics & numerical data ; Feasibility Studies ; Female ; Humans ; Hysterectomy - methods ; Hysterectomy - statistics & numerical data ; Placenta Accreta - surgery ; Pregnancy ; Prospective Studies ; randomized controlled trial ; surgical technique ; Treatment Outcome ; uterine sparing surgery]]></subject><ispartof>American journal of obstetrics &amp; gynecology MFM, 2024-06, Vol.6 (6), p.101333, Article 101333</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-677aef9409dbfd0ac373191d74b91ee9d7486e41f5f7bbaf372757675c09005f3</citedby><cites>FETCH-LOGICAL-c362t-677aef9409dbfd0ac373191d74b91ee9d7486e41f5f7bbaf372757675c09005f3</cites><orcidid>0000-0001-5639-9127</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38458362$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nieto-Calvache, Álbaro José</creatorcontrib><creatorcontrib>Aryananda, Rozi Aditya</creatorcontrib><creatorcontrib>Palacios-Jaraquemada, José Miguel</creatorcontrib><creatorcontrib>Cininta, Nareswari</creatorcontrib><creatorcontrib>Grace, Ariani</creatorcontrib><creatorcontrib>Benavides-Calvache, Juan Pablo</creatorcontrib><creatorcontrib>Campos, Clara Ivette</creatorcontrib><creatorcontrib>Messa-Bryon, Adriana</creatorcontrib><creatorcontrib>Vallecilla, Liliana</creatorcontrib><creatorcontrib>Sarria, Daniela</creatorcontrib><creatorcontrib>Galindo, Juan Sebastian</creatorcontrib><creatorcontrib>Galindo-Velasco, Valentina</creatorcontrib><creatorcontrib>Rivera-Torres, Luisa Fernanda</creatorcontrib><creatorcontrib>Burgos-Luna, Juan Manuel</creatorcontrib><creatorcontrib>Bhide, Amarnath</creatorcontrib><title>One-step conservative surgery vs hysterectomy for placenta accreta spectrum: a feasibility randomized controlled trial</title><title>American journal of obstetrics &amp; gynecology MFM</title><addtitle>Am J Obstet Gynecol MFM</addtitle><description>Placenta accreta spectrum is a serious condition associated with significant maternal morbidity and even mortality. The recommended treatment is hysterectomy. An alternative is 1-step conservative surgery, which involves the en bloc resection of the myometrium affected by placenta accreta spectrum along with the placenta, followed by uterine reconstruction. Currently, there are no studies comparing the 2 techniques in the setting of a randomized controlled trial. We performed a prospectively registered multicenter randomized controlled trial comparing hysterectomy with 1-step conservative surgery. The aim was to collect feasibility and clinical outcomes of the 2 techniques in women assigned to hysterectomy or 1-step conservative surgery. In addition to assessing participants’ willingness to be randomized, we also collected data on intraoperative blood loss, transfusion requirement, serious adverse event, and other clinical outcomes. Sixty women with strong antenatal suspicion of placenta accreta spectrum were assigned randomly to either hysterectomy (n=31) or 1-step conservative surgery (n=29). During a 20-month period, 60 of the 64 eligible patients (93.7%) underwent randomization. Intention-to-treat analysis showed that the clinical outcomes for 1-step conservative surgery were comparable to those of hysterectomy (median intraoperative blood loss, 1740 mL [interquartile range, 1010–2410] vs 1500 mL [interquartile range, 1122–2753]; odds ratio, 1 [1–1]; P=.942; median duration of surgery, 135 minutes [interquartile range, 111–180] vs 155 minutes [interquartile range, 120–185]; odds ratio, 0.99 [0.98–1]; P=.151; transfusion rate, 58.6% vs 61.3%; odds ratio, 0.96 [0.83–1.76]; P=.768; and adverse event rate, 17.2% vs 9.7%; odds ratio, 1.77 [0.43–10.19]; P=.398; respectively). In the subgroup of women with type 1 class on topographic classification, all participants allocated to 1-step surgery had successful outcomes, which were superior to those of hysterectomy. This was evidenced by the shorter surgery duration (median, 125 [interquartile range, 98–128] vs 180 [129–226] minutes; P=.002), lower transfusion rates (46.2% vs 82.4%), and fewer units of red blood cells transfused (median, 1 [interquartile range, 1–1.8] vs 3 [interquartile range, 2–4] units; P=.007). A randomized controlled trial comparing 2 surgical techniques for the treatment of placenta accreta spectrum is feasible. One-step conservative repair is a valid alternative to hysterectomy in the large majority of cases, but this can only be ascertained following intraoperative surgical staging. El resumen está disponible en Español al final del artículo.</description><subject>accreta</subject><subject>Adult</subject><subject>Blood Loss, Surgical - prevention &amp; control</subject><subject>Blood Loss, Surgical - statistics &amp; numerical data</subject><subject>Blood Transfusion - methods</subject><subject>Blood Transfusion - statistics &amp; numerical data</subject><subject>Cesarean Section - adverse effects</subject><subject>Cesarean Section - methods</subject><subject>Cesarean Section - statistics &amp; numerical data</subject><subject>Conservative Treatment - methods</subject><subject>Conservative Treatment - statistics &amp; numerical data</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Hysterectomy - methods</subject><subject>Hysterectomy - statistics &amp; numerical data</subject><subject>Placenta Accreta - surgery</subject><subject>Pregnancy</subject><subject>Prospective Studies</subject><subject>randomized controlled trial</subject><subject>surgical technique</subject><subject>Treatment Outcome</subject><subject>uterine sparing surgery</subject><issn>2589-9333</issn><issn>2589-9333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtu1TAQhi0EolXpGyDkJZuc-hrHLJBQVS5SpW5gbTnOuPgoiYOdRApPj6MUxKqr-TXzz-1D6C0lJ0pofXM-2XN8HPyJESb2FOf8BbpkstGVLvrlf_oCXed8JoQwKoRk9Wt0wRshG16zS7Q-jFDlGSbs4pghrXYOK-C8pEdIG14z_rmVcgI3x2HDPiY89dbBOFtsnUtQYp5KNS3DB2yxB5tDG_owbzjZsYtD-A3dPnxOse-LnFOw_Rv0yts-w_VTvEI_Pt99v_1a3T98-Xb76b5y5bq5qpWy4LUgumt9R6zjilNNOyVaTQF0EU0NgnrpVdtazxVTUtVKOqIJkZ5foffH3CnFXwvk2QwhO-h7O0JcsmFaCqUaJmmxisPqUsw5gTdTCoNNm6HE7NDN2RzQzQ7dHNBL27unDUs7QPev6S_iYvh4GKD8uQZIJrsAo4Mu7FRNF8PzG_4A6QyW_Q</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Nieto-Calvache, Álbaro José</creator><creator>Aryananda, Rozi Aditya</creator><creator>Palacios-Jaraquemada, José Miguel</creator><creator>Cininta, Nareswari</creator><creator>Grace, Ariani</creator><creator>Benavides-Calvache, Juan Pablo</creator><creator>Campos, Clara Ivette</creator><creator>Messa-Bryon, Adriana</creator><creator>Vallecilla, Liliana</creator><creator>Sarria, Daniela</creator><creator>Galindo, Juan Sebastian</creator><creator>Galindo-Velasco, Valentina</creator><creator>Rivera-Torres, Luisa Fernanda</creator><creator>Burgos-Luna, Juan Manuel</creator><creator>Bhide, Amarnath</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5639-9127</orcidid></search><sort><creationdate>20240601</creationdate><title>One-step conservative surgery vs hysterectomy for placenta accreta spectrum: a feasibility randomized controlled trial</title><author>Nieto-Calvache, Álbaro José ; Aryananda, Rozi Aditya ; Palacios-Jaraquemada, José Miguel ; Cininta, Nareswari ; Grace, Ariani ; Benavides-Calvache, Juan Pablo ; Campos, Clara Ivette ; Messa-Bryon, Adriana ; Vallecilla, Liliana ; Sarria, Daniela ; Galindo, Juan Sebastian ; Galindo-Velasco, Valentina ; Rivera-Torres, Luisa Fernanda ; Burgos-Luna, Juan Manuel ; Bhide, Amarnath</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-677aef9409dbfd0ac373191d74b91ee9d7486e41f5f7bbaf372757675c09005f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>accreta</topic><topic>Adult</topic><topic>Blood Loss, Surgical - prevention &amp; control</topic><topic>Blood Loss, Surgical - statistics &amp; numerical data</topic><topic>Blood Transfusion - methods</topic><topic>Blood Transfusion - statistics &amp; numerical data</topic><topic>Cesarean Section - adverse effects</topic><topic>Cesarean Section - methods</topic><topic>Cesarean Section - statistics &amp; numerical data</topic><topic>Conservative Treatment - methods</topic><topic>Conservative Treatment - statistics &amp; numerical data</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Hysterectomy - methods</topic><topic>Hysterectomy - statistics &amp; numerical data</topic><topic>Placenta Accreta - surgery</topic><topic>Pregnancy</topic><topic>Prospective Studies</topic><topic>randomized controlled trial</topic><topic>surgical technique</topic><topic>Treatment Outcome</topic><topic>uterine sparing surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nieto-Calvache, Álbaro José</creatorcontrib><creatorcontrib>Aryananda, Rozi Aditya</creatorcontrib><creatorcontrib>Palacios-Jaraquemada, José Miguel</creatorcontrib><creatorcontrib>Cininta, Nareswari</creatorcontrib><creatorcontrib>Grace, Ariani</creatorcontrib><creatorcontrib>Benavides-Calvache, Juan Pablo</creatorcontrib><creatorcontrib>Campos, Clara Ivette</creatorcontrib><creatorcontrib>Messa-Bryon, Adriana</creatorcontrib><creatorcontrib>Vallecilla, Liliana</creatorcontrib><creatorcontrib>Sarria, Daniela</creatorcontrib><creatorcontrib>Galindo, Juan Sebastian</creatorcontrib><creatorcontrib>Galindo-Velasco, Valentina</creatorcontrib><creatorcontrib>Rivera-Torres, Luisa Fernanda</creatorcontrib><creatorcontrib>Burgos-Luna, Juan Manuel</creatorcontrib><creatorcontrib>Bhide, Amarnath</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics &amp; gynecology MFM</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nieto-Calvache, Álbaro José</au><au>Aryananda, Rozi Aditya</au><au>Palacios-Jaraquemada, José Miguel</au><au>Cininta, Nareswari</au><au>Grace, Ariani</au><au>Benavides-Calvache, Juan Pablo</au><au>Campos, Clara Ivette</au><au>Messa-Bryon, Adriana</au><au>Vallecilla, Liliana</au><au>Sarria, Daniela</au><au>Galindo, Juan Sebastian</au><au>Galindo-Velasco, Valentina</au><au>Rivera-Torres, Luisa Fernanda</au><au>Burgos-Luna, Juan Manuel</au><au>Bhide, Amarnath</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>One-step conservative surgery vs hysterectomy for placenta accreta spectrum: a feasibility randomized controlled trial</atitle><jtitle>American journal of obstetrics &amp; gynecology MFM</jtitle><addtitle>Am J Obstet Gynecol MFM</addtitle><date>2024-06-01</date><risdate>2024</risdate><volume>6</volume><issue>6</issue><spage>101333</spage><pages>101333-</pages><artnum>101333</artnum><issn>2589-9333</issn><eissn>2589-9333</eissn><abstract>Placenta accreta spectrum is a serious condition associated with significant maternal morbidity and even mortality. The recommended treatment is hysterectomy. An alternative is 1-step conservative surgery, which involves the en bloc resection of the myometrium affected by placenta accreta spectrum along with the placenta, followed by uterine reconstruction. Currently, there are no studies comparing the 2 techniques in the setting of a randomized controlled trial. We performed a prospectively registered multicenter randomized controlled trial comparing hysterectomy with 1-step conservative surgery. The aim was to collect feasibility and clinical outcomes of the 2 techniques in women assigned to hysterectomy or 1-step conservative surgery. In addition to assessing participants’ willingness to be randomized, we also collected data on intraoperative blood loss, transfusion requirement, serious adverse event, and other clinical outcomes. Sixty women with strong antenatal suspicion of placenta accreta spectrum were assigned randomly to either hysterectomy (n=31) or 1-step conservative surgery (n=29). During a 20-month period, 60 of the 64 eligible patients (93.7%) underwent randomization. Intention-to-treat analysis showed that the clinical outcomes for 1-step conservative surgery were comparable to those of hysterectomy (median intraoperative blood loss, 1740 mL [interquartile range, 1010–2410] vs 1500 mL [interquartile range, 1122–2753]; odds ratio, 1 [1–1]; P=.942; median duration of surgery, 135 minutes [interquartile range, 111–180] vs 155 minutes [interquartile range, 120–185]; odds ratio, 0.99 [0.98–1]; P=.151; transfusion rate, 58.6% vs 61.3%; odds ratio, 0.96 [0.83–1.76]; P=.768; and adverse event rate, 17.2% vs 9.7%; odds ratio, 1.77 [0.43–10.19]; P=.398; respectively). In the subgroup of women with type 1 class on topographic classification, all participants allocated to 1-step surgery had successful outcomes, which were superior to those of hysterectomy. This was evidenced by the shorter surgery duration (median, 125 [interquartile range, 98–128] vs 180 [129–226] minutes; P=.002), lower transfusion rates (46.2% vs 82.4%), and fewer units of red blood cells transfused (median, 1 [interquartile range, 1–1.8] vs 3 [interquartile range, 2–4] units; P=.007). A randomized controlled trial comparing 2 surgical techniques for the treatment of placenta accreta spectrum is feasible. One-step conservative repair is a valid alternative to hysterectomy in the large majority of cases, but this can only be ascertained following intraoperative surgical staging. El resumen está disponible en Español al final del artículo.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38458362</pmid><doi>10.1016/j.ajogmf.2024.101333</doi><orcidid>https://orcid.org/0000-0001-5639-9127</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2589-9333
ispartof American journal of obstetrics & gynecology MFM, 2024-06, Vol.6 (6), p.101333, Article 101333
issn 2589-9333
2589-9333
language eng
recordid cdi_proquest_miscellaneous_2954778251
source MEDLINE; Alma/SFX Local Collection
subjects accreta
Adult
Blood Loss, Surgical - prevention & control
Blood Loss, Surgical - statistics & numerical data
Blood Transfusion - methods
Blood Transfusion - statistics & numerical data
Cesarean Section - adverse effects
Cesarean Section - methods
Cesarean Section - statistics & numerical data
Conservative Treatment - methods
Conservative Treatment - statistics & numerical data
Feasibility Studies
Female
Humans
Hysterectomy - methods
Hysterectomy - statistics & numerical data
Placenta Accreta - surgery
Pregnancy
Prospective Studies
randomized controlled trial
surgical technique
Treatment Outcome
uterine sparing surgery
title One-step conservative surgery vs hysterectomy for placenta accreta spectrum: a feasibility randomized controlled trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A15%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=One-step%20conservative%20surgery%20vs%20hysterectomy%20for%20placenta%20accreta%20spectrum:%20a%20feasibility%20randomized%20controlled%20trial&rft.jtitle=American%20journal%20of%20obstetrics%20&%20gynecology%20MFM&rft.au=Nieto-Calvache,%20%C3%81lbaro%20Jos%C3%A9&rft.date=2024-06-01&rft.volume=6&rft.issue=6&rft.spage=101333&rft.pages=101333-&rft.artnum=101333&rft.issn=2589-9333&rft.eissn=2589-9333&rft_id=info:doi/10.1016/j.ajogmf.2024.101333&rft_dat=%3Cproquest_cross%3E2954778251%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2954778251&rft_id=info:pmid/38458362&rft_els_id=S2589933324000594&rfr_iscdi=true